Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for Tender Results, browse documents here.


FAX

Tender Results

To: From: Date: All Suppliers and Wholesalers Yvonne Chen 30 January 2009 No of Pages (including this one): 3

Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12h February 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 March 2009, reference pricing of non-tender winning brand will occur on 1 May 2009 and Sole Subsidised Supply commences on 1 August 2009.

The decisions were as follows:

Chemical Name Amoxycillin clavulanate

Presentation; Pack size and type

Current Subsidy

New tender subsidy $25.10

Sole supply brand (Supplier) Synermox (Douglas)

Brands affected by reference pricing and delisting Augmentin (GSK)

Tab amoxycillin 500 mg with $6.40 potassium clavulanate 125 mg; 100 (20 tablets) tablets, bottle

A235113 - qA7633


Chemical Name Ibuprofen Mebendazole Simvastatin Simvastatin Simvastatin Simvastatin

Presentation; Pack size and type Tab 200 mg; 1,000 tablets, blister Tab 100 mg; 24 tablets, blister Tab 10 mg; 90 tablets, blister Tab 20 mg; 90 tablets, blister Tab 40 mg; 90 tablets, blister Tab 80 mg; 90 tablets, blister

Current Subsidy $17.80 $15.16 $8.33* (30 tablets) $10.13* (30 tablets) $18.00* (30 tablets) $21.00* (30 tablets)

New tender subsidy $16.00 $17.28 $2.05 $3.00 $5.35 $11.65

Sole supply brand (Supplier) Ethics Ibuprofen (Multichem) DeWorm (Multichem) Arrow-Simva 10 (Arrow) Arrow-Simva 20 (Arrow) Arrow-Simva 40 (Arrow) Arrow-Simva 80 (Arrow)

Brands affected by reference pricing and delisting I-Profen (Multichem) Vermox (Janssen-Cilag) Lipex (MSD) SimvaRex (Rex) Lipex (MSD) SimvaRex (Rex) Lipex (MSD) SimvaRex (Rex) Lipex (MSD) SimvaRex (Rex)

* SimvaRex 10 mg, 20 mg, 40 mg and 80 mg, in 30 tablet packs, are also currently fully funded.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 March 2009; DV Limits and DV pharmaceuticals will apply from 1 May 2009; Delisting of other brands in Section H will occur on 1 May 2009.

Presentation; Pack size and type Tab amoxycillin 500 mg with Amoxycillin clavulanate potassium clavulanate 125 mg; 100 tablets, bottle Chemical Name Hospital Supply Brand (Supplier) Synermox (Douglas) Pack Price $25.10 DV Limit 1% DV Pharmaceuticals Brand Name Augmentin Apo-Simvastatin Lipex Simlo SimStatin Simvalip SimvaRex Zocor Apo-Simvastatin Lipex Simlo SimStatin Simvalip SimvaRex Zocor Apo-Simvastatin Lipex Simlo SimStatin Simvalip SimvaRex Zocor

Simvastatin

Tab 10 mg; 90 tablets, blister

Arrow-Simva 10 (Arrow)

$2.05

1%

Simvastatin

Tab 20 mg; 90 tablets, blister

Arrow-Simva 20 (Arrow)

$3.00

1%

Simvastatin

Tab 40 mg; 90 tablets, blister

Arrow-Simva 40 (Arrow)

$5.35

1%

A235113 - qA7633


Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier)

Pack Price

DV Limit

Simvastatin

Tab 80 mg; 90 tablets, blister

Arrow-Simva 80 (Arrow)

$11.65

1%

DV Pharmaceuticals Brand Name Apo-Simvastatin Lipex Simlo SimStatin Simvalip SimvaRex

3. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 March 2009 and DV Limits and DV Pharmaceuticals will apply from 1 May 2009.

The decisions were as follows:

Chemical Name Mebendazole

Presentation; Pack size and type Tab 100 mg; 24 tablets, blister

Hospital Supply Brand (Supplier) DeWorm (Multichem)

Pack Price $17.28

DV Limit 1%

DV Pharmaceuticals Brand Name (Supplier) Vermox (Janssen-Cilag)

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to tender dated 15 December 2006 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. Yours sincerely

Yvonne Chen Tender Analyst

A235113 - qA7633

Metadata

Title

Tender Results

Abstract

FAX Tender Results To: From: Date: All Suppliers and Wholesalers Yvonne Chen 30 January 2009 No of Pages (including this one): 3 Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.